Status
Conditions
About
This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Soraya Fenniche, MD; Nesrine Mejri, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal